US Biomax

Thumb	Name	Description	Cores	Cases	Price
Thumb	Name	Description	Cores	Cases	Unstained	H&E	Trial
	BR952	Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER/PR/p53 IHC results and survival data, 31 cases/95 cores	95	31		$395.00
	CO952	Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases/95 cores, replaced by CO952a	95	30	$1,195.00	$1,195.00
	CO952a	Colorectal cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases/95 cores.	95	30	$1,195.00	$1,195.00
	CO953	Colon cancer tissue array with matched normal adjacent and matched or unmatched metastatic carcinoma tissue, with TNM, clinical stage and survival data, 39 cases/95 cores, replacing CO952a	95	39	$1,195.00	$1,195.00
	CO953a	Colon adenocarcinoma and metastatic adenocarcinoma tissue array, with matched colon tissue, including survival data, pathology grade, TNM and clinical stage, 39 cases/96 cores, replacing CO953	96	39	$1,195.00	$1,195.00
	FeOrg-N090-01	adrenal, kidney, bladder, ureter, pituitary, cerebrum, hippocampus, thalamus, spinal cord, nerve, thymus, spleen, diaphragm, sternum, rib, skin.	90	5	$420.00	$420.00
	HBiDC122Su01	Bile ducts cancer, 91 cases.31 cases have tumor and matched NAT*, 60 cases have tumor. With survival information. Follow up 5-9 years. Relapse information available.	122	91	$937.50	$937.50
	HBla-Uro105Sur-01	Bladder cancer tissue array, 59 cases. 46 cases have tumor and matched normal adjacent tissue (NAT)	105	59	$780.00	$780.00
	HBlaU066Su01	Bladder carcinoma tissue microarray (56 cases) and normal adjacent tissue. With survival data. Replaces HBla-Uro105Sur-01	66	56	$547.00	$547.00
	HBraG177Su01	Glioma 177 cases with survival information：tumor (1 core/case).With survival information. Follow up 5-9 years. Relapse information available.	177	177	$2,344.00	$2,344.00
	HBre-Duc090Sur-01	Breast tissue array, normal adjacent tissue of HBre-Duc170Sur-01, 90 cases. 1 core/case, with survival information	90	90	$465.00	$465.00	$125.00
	HBre-Duc140Sur-02	Breast carcinoma, 140 cases. 1 core/case with survival data	140	140	$1,405.00	$1,405.00	$425.00
	HBreD030PG03	30 cases,Carcinoma	30	30	$94.00	$94.00
	HBreD070CS02	Breast invasive ductal carcinoma (69 cases) and NAT* (11 cases). 2 cases are from men.	70	70	$234.00	$234.00
	HBreD139Su01	Breast carcinoma, 139 cases.With survival information. Follow up 5-9 years. Relapse information available.	139	139	$1,406.00	$1,406.00
	HBreD140Su04	Breast carcinoma, 140 cases. With survival information. Follow up 5-9 years. Relapse information available.	140	140	$1,406.00	$1,406.00
	HBreD140Su05	Breast carcinoma, 140 cases.With survival information. Follow up 5-9 years. Relapse information available.	140	140	$1,406.00	$1,406.00
	HBreD140Su07	Breast cancer tissue array, including pathology grade, TNM and clinical stage (reference AJCC 6th version), survival data (Surgery date 2004.8--2008.12. Visit date 2014.7. Being followed up for 5.6--10 years), and IHC marker (ER, PR, Her-2, Ki67 and P53), 140 cases/140 cores	140	140	$1,414.00	$1,414.00
	HBreD145Su01	Breast carcinoma, 145 cases. With survival information. Follow up 5-9 years. Relapse information available.	145	145	$1,562.00	$1,562.00
	HBreD145Su02	Breast carcinoma tissue array, 145 cases, 1 core/case. Clinical stage 0, I, II, III. With survival data. Replacing HBre-Duc150Sur-02 (141 same cases)	145	145	$1,484.00	$1,484.00
	HCol-Ade180Sur-02	Colon adenocarcinoma tissue array with survival and TNM information.data, 93 cases, 87 cases with tumor and normal adjacent tissue (NAT).	180	93	$1,250.00	$1,250.00
	HCol-Ade180Sur-03	Colon cancer tissue array, 90 cases of tumor and matched normal adjacent tissue (1 core/case), with survival data	180	90	$1,090.00	$1,090.00
	HCol-Ade180Sur-04	Colon cancer tissue array 90 cases of tumor and matched normal adjacent tissue, respectively (1 core/case)	180	90	$1,250.00	$1,250.00
	HCol-Ade180Sur-05	Colon adenocarcinoma,90 cases, tumor and NAT*. With survival information. Follow up 5-9 years. Relapse information available.	180	90	$1,562.00	$1,562.00
	HCol-Ade180Sur-08	Colon cancer tissue array 90 cases of tumor and matched normal adjacent tissue, respectively (1 core/case). With survival information. Follow up 5-9 years. Relapse information available.	180	90	$1,440.00	$1,440.00
	HColA030PG05	30 cases,tumor	30	15	$94.00	$94.00
	HColA160Su02	Colon adenocarcinoma,100 cases, 160 cores.With survival information. 100 cases tumor (1 core/tumor),60 cases (1 core/NAT.)Surgery date from 2005.7-2010.12.visit date 2015.9.Being fowllowed up for 5-9 years. 36 cases deceased.	150	30	$1,250.00	$1,250.00
	HColA180Su09	Colon adenocarcinoma,100 cases, 80 cases have tumor and NAT*. With survival information. Follow up 5-9 years. Relapse information available.	180	100	$1,580.00	$1,580.00
	HColA180Su10	Colon adenocarcinoma,100 cases, 80 cases have tumor and NAT*. With survival information. Follow up 5-9 years. Relapse information available.	180	100	$1,406.00	$1,406.00
	HColA180Su11	Colon adenocarcinoma,93 cases, 87 cases have tumor and NAT*.	180	93	$1,406.00	$1,406.00
	HColA180Su12	Colon adenoadenocarcinoma,93 cases, 87 cases have tumor and NAT*. With survival information. Follow up 5-9 years. Relapse information available.	180	93	$1,406.00	$1,406.00
	HColA180Su14	Colon adenoadenocarcinoma,90 cases have tumor and NAT*. With survival information. Follow up 5-9 years. Relapse information available.	180	90	$1,290.00	$1,290.00
	HColA180Su15	Colon adenoadenocarcinoma,101 cases, 79 cases have tumor and NAT*.	180	101	$1,580.00	$1,580.00
	HColA180Su17	Colon adenoadenocarcinoma,101 cases, 79 cases have tumor and NAT*.With survival information. Follow up 5-9 years. Relapse information available.	180	101	$1,406.00	$1,406.00
	HEso-Squ172Sur-01	Esophageal squamous cell ccancer tissue array (86 cases), 78 cases have tumor and matched normal adjacent tissue (1 core/case), with survival data	172	86	$1,250.00	$1,250.00
	HEso-Squ172Sur-02	Esophageal squamous cell cancer tissue array (93 cases), 79 cases have tumor and matched normal adjacent tissue (1 core/case), with survival data	172	93	$1,090.00	$1,090.00
	HEso-Squ180Sur-01	Esophagus squamous carcinoma, 95 cases, tumor and matched NAT with survival information.	180	95	$1,562.00	$1,562.00
	HEso-Squ180Sur-02	Esophagus squamous carcinoma, 90 cases, tumor and matched NAT with survival information.	180	90	$1,250.00	$1,250.00
	HEso-Squ180Sur-03	Esophagus squamous cell carcinoma tissue array, 93 cases, tumor and matched NAT with survival information.	180	93	$1,406.00	$1,406.00
	HEsoS105Su01	Esophagus squamous cell carcinoma, 50 cases have tumor(1 core/case) and matched NAT* (1 core/case). 5 cases have tumor tissue(2 cores/case).	105	50	$938.00	$938.00
	HEsoS180Su04	esophagus carcinoma,100 cases, tumor and matched NAT* with survival information.	180	100	$1,562.00	$1,562.00
	HEsoS180Su05	Esophagus carcinoma,103 cases, tumor and matched NAT* with survival information.	180	103	$1,562.00	$1,562.00
	HEsoS180Su06	Esophageal cancer tissue array with matched cancer adjacent esophageal tissue and survival information, including pathology grade, TNM and clinical stage, 103 cases/180 cores. With survival information. Follow up 5-9 years. Relapse information available.	180	103	$1,328.00	$1,328.00
	HEsoS180Su07	Esophagus squamous cell carcinoma (103 cases), 77 cases have tumor (1 core/case) and matched normal adjacent tissue (1 core/case).With survival information. Follow up 5-9 years. Relapse information available.	180	103	$1,406.00	$1,406.00
	HGal-Ade100PG-01	Gallbladder carcinoma tissue array, 80 cases. 20 cases have tumor and normal adjacent tissue. 60 cases have only tumor	100	80	$465.00	$465.00
	HGEj-Ade130Sur-01	Gastroesophageal junctional cancer tissue array, 65 cases and matched normal adjacent tissue, with survival data	130	65	$780.00	$780.00
	HKid-CRC180Sur-01	Kidney clear cell carcinoma tissue array, 90 cases of tumor and matched normal adjacent tissue (1 core/case), with survival data	180	90	$1,406.00	$1,406.00
	HKid-CRCC150CS-01	Kidney clear cell carcinoma tissue array, 75 cases, tumor and matched normal adjacent tissue.	150	75	$625.00	$625.00
	HKidE180Su02	Kidney cancer tissue array with matched cancer adjacent normal tissue and survival information, including pathology grade, TNM and clinical stage, 150 cases/180 cores	180	150	$1,406.00	$1,406.00
	HKidE180Su03	Clear cell carcinoma, 90 cases.	180	90	$1,406.00	$1,406.00
	HLiv-HCC180Sur-02	HLiver cancer tissue array, 90 cases of tumor and matched normal adjacent tissue (1 core/case), with survival data	180	90	$1,560.00	$1,560.00
	HLiv-HCC180Sur-03	Liver cancer tissue array (90 cases) and normal adjacent tissue (NAT), 1 core/case, with survival data	180	90	$1,406.00	$1,406.00
	HLiv-HCC180Sur-04	Hepatocellular carcinoma tissue array, clinical stage I-III, 90 cases. Tumor and normal adjacent tissue. With survival data.	180	90	$1,600.00	$1,600.00
	HLiv-HCC180Sur-05	Hepatocellular carcinoma tissue array, 95 cases. Tumor and normal adjacent tissue.	180	95	$1,600.00	$1,600.00
	HLivH070Su01	Hepatocellular carcinoma, 32 cases. Tumor and NAT*.With survival information. Follow up 5-9 years. Relapse information available	70	32	$469.00	$469.00
	HLivH090Su01	Hepatocellular carcinoma, 90 cases.	90	90	$1,875.00	$1,875.00
	HLivH150CS04	liver adenocarcinoma, 75 cases.	150	75	$391.00	$391.00
	HLivH180Su10	Hepatocellular carcinoma, 90 cases. Tumor and NAT*. With survival information. Follow up 5-9 years. Relapse information available.	180	93	$1,562.00	$1,562.00
	HLivH180Su14	Hepatocellular carcinoma, 90 cases. Tumor and NAT*. With survival information. Follow up 5-9 years. Relapse information available	180	90	$1,875.00	$1,875.00
	HLivHCC180Bch01	Hepatocellular carcinoma, 49 cases. Tumor and NAT*.	180	49	$465.00	$465.00
	HLug-Ade060PG-01	Human lung carcinoma tissue array with matched normal adjacent tissue	60	30	$188.00	$188.00
	HLug-Ade150Sur-01	Lung adenocarcinoma tissue array, 75 cases of tumor and matched normal adjacent tissue (NAT), 1 core/case with TNM and survival information.	150	75	$935.00	$935.00
	HLug-Ade150Sur-02	Lung adenocarcinoma tissue array (75 cases) and matched normal adjacent tissue (1 core/case), with survival data	150	75	$935.00	$935.00
	HLug-Squ150Sur-01	Lung squamous cell cancer tissue array, 75 cases. Tumor and matched normal adjacent tissue (NAT), 1 core/case with TNM detail information and survival data.	150	75	$1,090.00	$1,090.00
	HLug-Squ150Sur-02	Lung squamous cell carcinoma tissue array (75 cases) and matched normal adjacent tissue (NAT, 1 core/case), with survival data	150	75	$938.00	$938.00
	HLugA180Su01	Lung carcinoma,90 cases, tumor and matched NAT* with survival information.	180	90	$1,406.00	$1,406.00
	HLugA180Su03	Lung carcinoma,92 cases, tumor and matched NAT* with survival information.replacing Hlug-Ade150Sur-01	180	92	$1,406.00	$1,406.00
	HlugA180Su05	Lung cancer with matched adjacent tissue array, including pathology grade, clinical stage(AJCC 7.0)I II III IV, with TNM score, survival information available. Surgery date 2004.7-2009.6, visit date 2014.8. Being followed up for 5-10 years, with FISH information (EGFR), 94 cases/180 cores	180	94	$1,562.00	$1,562.00
	HLugA180Su06	Lung carcinoma,94 cases, tumor and matched NAT* with survival information.	180	94	$1,562.00	$1,562.00
	HLugS180su-01	Lung squamous carcinoma,90 cases, tumor and matched NAT* with survival information.	180	90	$1,562.00	$1,562.00
	HNasN132Su01	Nasopharyngeal carcinoma, tumor only	132	132	$1,875.00	$1,875.00
	HOvaC154Su01	Multiple ovary cancer tissue array (2014 WHO classification), including pathology grade, TNM and clinical stage (reference AJCC 7th version), With survival information. Follow up 5-9 years. Relapse information available. Ki67, EGFR, PDL1 information added. 154 cases/154 cores, replacing HOvaC160Su01	154	154	$1,875.00	$1,875.00
	HPan-Ade120Sur-01	Pancreatic carcinoma, 63 cases, with survival information.	120	63	$960.00	$960.00
	HPan-Ade170Sur-01	Pancreatic adenocarcinoma, 99 cases, tumor and matched NAT*. With survival information. Follow up 5-9 years. Relapse information available.	170	99	$1,406.00	$1,406.00
	HPan-Ade180Sur-02	Pancreatic cancer tissue array, 90 cases of carcinoma and matched normal adjacent tissue (nat, 1 core/case), with survival data. With survival information. Follow up 5-9 years. Relapse information available.	100	100	$1,560.00	$1,560.00
	HPanA020PG02	10 cases,tumor and NAT	20	10	$78.00	$78.00
	HPro-Ade96Sur-01	Prostate adenocarcinoma tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores and survival data, 40 cases/96 cores	95	40	$1,560.00	$1,560.00
	HRaU-Uro050Sur-01	Normal adjacent tissue of urothelium carcinoma,50 cases, with survival information.	50	50	$156.00	$156.00
	HRaU-Uro120Sur-01	Renal pelvis carcinoma and ureter carcinoma tissue array, 120 cases, 1 core/case, with survival data	120	120	$780.00	$780.00
	HRec-Ade180Sur-01	Rectal cancer tissue array (90 cases) and matched normal adjacent tissue, with survival data	180	90	$1,250.00	$1,250.00
	HRec-Ade180Sur-02	Rectal cancer tissue array (90 cases) and matched normal adjacent tissue, with survival data	180	90	$1,090.00	$1,090.00
	HRec-Ade180Sur-03	Rectum adenocarcinoma tissue microarray with survival information, with matched normal adjacent tissue, 90 cases/180 cores;	180	90	$1,484.00	$1,484.00
	HRec-Ade180Sur-04	Rectum adenocarcinoma tissue microarray with survival information, with matched normal adjacent tissue, 90 cases/180 cores	180	90	$1,406.00	$1,406.00
	HRec-Ade180Sur-05	Rectum adenocarcinoma (90 cases), tumor and matched NAT*.With survival information. Follow up 5-9 years. Relapse information available	180	90	$1,250.00	$1,250.00
	HSkiC100PT01	Skin carcinoma, 95 cases. Include basal cell carcinoma, squamous cell carcinoma, melanoma. Normal skin, 3 cases. 15 cases have survival information.	100	95	$312.00	$312.00
	HStm-A150Su-01	gastric carcinoma, 75 cases. With survival information. Follow up 5-9 years. Relapse information available	150	95	$1,288.00	$1,288.00
	HStm-Ade167Sur-01	Stomach cancer tissue array (92 cases) and matched normal adjacent tissue, with survival data	167	92	$1,250.00	$1,250.00
	HStm-Ade178Sur-01	Stomach cancer tissue array (111 cases). 67 cases have tumor and matched (NAT), with survival data	178	111	$1,560.00	$1,560.00
	HStm-Ade180Sur-02	Stomach cancer tissue array, 90 cases/180 cores. With survival information. Follow up 5-9 years. Relapse information available.	180	90	$1,090.00	$1,090.00
	HStm-Ade180Sur-03	Gastric adenocarcinoma,90 cases, tumor and matched NAT* .With survival information. Follow up 5-9 years. Relapse information available.	180	90	$1,406.00	$1,406.00
	HStm-Ade180Sur-04	Stomach cancer tissue array, 90 cases, tumor and matched normal adjacent tissue (NAT), with survival data	180	90	$1,484.00	$1,484.00
	HStm-Ade180Sur-05	Gastric adenocarcinoma tissue array,90 cases, tumor and matched normal adjacent tissue with survival information	180	90	$1,484.00	$1,484.00	$714.00
	HStm-Ade180Sur-06	Gastric adenocarcinoma,90 cases, tumor and matched NAT* with survival information.	180	90	$1,328.00	$1,328.00
	HStm-Ade180Sur-07	Stomach cancer tissue array, 90 cases, tumor and matched normal adjacent tissue (NAT) with survival information.	180	90	$1,250.00	$1,250.00	$380.00
	HStmA180Su08	Stomach cancer tissue array with matched adjacent normal stomach tissue, including pathology grade, TNM and clinical stage, 100 cases/180 cores. With survival information. Follow up 5-9 years. Relapse information available.	180	100	$1,580.00	$1,580.00
	HStmA180Su09	gastric adenocarcinoma, 90 cases, tumor and NAT*.	180	90	$1,406.00	$1,406.00
	HStmA180Su11	gastric adenocarcinoma, 90 cases, 90 cases have tumor and NAT*.	180	90	$1,406.00	$1,406.00
	HStmA180Su13	Gastric adenocarcinoma, 96 cases, 84 cases have tumor and NAT*, 12cases have tumor only. With survival information. Follow up 5-9 years. Relapse information available	180	96	$1,250.00	$1,250.00
	HStmA180Su15	Gastric adenocarcinoma, 96 cases, 82 cases have tumor and NAT*, 16 cases have tumor only. With survival information. Follow up 5-9 years. Relapse information available	180	98	$1,563.00	$1,563.00
	HUteS168Su01	Human cervix tissue .With survival information. Follow up 5-9 years. Relapse information available.	168	126	$1,406.00	$1,406.00

Showing 1 to 100 of 140 (2 Pages)